Abstract:Background Pulmonary perfusion defects have been observed in patients with coronavirus disease 2019 (COVID‐19). Currently, there is a need for further data on non‐contrast‐enhanced MRI in COVID patients. The early identification of heterogeneity in pulmonary perfusion defects among COVID‐19 patients is beneficial for their timely clinical intervention and management. Purpose To investigate the utility of phase‐resolved functional lung (PREFUL) MRI in detecting pulmonary perfusion disturbances in individuals with postacute COVID‐19 syndrome (PACS). Study Type Prospective. Subjects Forty‐four participants (19 females, mean age 64.1 years) with PACS and 44 healthy subjects (19 females, mean age 59.5 years). Moreover, among the 44 patients, there were 19 inpatients and 25 outpatients; 19 were female and 25 were male; 18 with non‐dyspnea and 26 with dyspnea. Field Strength/Sequence 3‐T, two‐dimensional (2D) spoiled gradient‐echo sequence. Assessment Ventilation and perfusion‐weighted maps were extracted from five coronal slices using PREFUL analysis. Subsequently, perfusion defect percentage (QDP), ventilation defect percentage (VDP), and ventilation‐perfusion match healthy (VQM) were calculated based on segmented lung parenchyma ventilation and perfusion‐weighted maps. Additionally, clinical features, including demographic data (such as sex and age) and serum biomarkers (such as D‐dimer levels), were evaluated. Statistical Tests Spearman correlation coefficients to explore relationships between clinical features and QDP, VDP, and VQM. Propensity score matching analysis to reduce the confounding bias between patients with PACS and healthy controls. The Mann–Whitney U tests and Chi‐squared tests to detect differences between groups. Multivariable linear regression analyses to identify factors related to QDP, VDP, and VQM. A P‐value <0.05 was considered statistically significant. Results QDP significantly exceeded that of healthy controls in individuals with PACS (39.8% ± 15.0% vs. 11.0% ± 4.9%) and was significantly higher in inpatients than in outpatients (46.8% ± 17.0% vs. 34.5% ± 10.8%). Moreover, males exhibited pulmonary perfusion defects significantly more frequently than females (43.9% ± 16.8% vs. 34.4% ± 10.2%), and dyspneic participants displayed significantly higher perfusion defects than non‐dyspneic patients (44.8% ± 15.8% vs. 32.6% ± 10.3%). QDP showed a significant positive relationship with age (β = 0.50) and D‐dimer level (β = 0.72). Data Conclusion PREFUL MRI may show pulmonary perfusion defects in patients with PACS. Furthermore, perfusion impairments may be more pronounced in males, inpatients, and dyspneic patients. Evidence Level 2 Technical Efficacy Stage 2

Estimating ventilation correlation coefficients in the lungs using PREFUL‐MRI in chronic obstructive pulmonary disease patients and healthy adults

Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI

Lung Volume Dependence and Repeatability of Hyperpolarized 129xe MRI Gas Uptake Metrics in Healthy Volunteers and Participants with COPD.

Comparison of Free‐Breathing 3D Phase‐Resolved Functional Lung (PREFUL) MRI With Dynamic 19F Ventilation MRI in Patients With Obstructive Lung Disease and Healthy Volunteers

Free-breathing 3D phase-resolved functional lung MRI vs breath-hold hyperpolarized 129Xe ventilation MRI in patients with chronic obstructive pulmonary disease and healthy volunteers

Phase-resolved MRI for measurement of pulmonary perfusion and ventilation defects in comparison with dynamic contrast-enhanced MRI and 129Xe MRI

Free‐Breathing Functional Pulmonary Proton MRI: A Novel Approach Using Voxel‐Wise Lung Ventilation (VOLVE) Assessment in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease

A novel approach to non-contrast, free-breathing functional lung MRI to generate dynamic measures of ventilation (V) and perfusion (Q).

PREFUL MRI Depicts Dual Bronchodilator Changes in COPD: A Retrospective Analysis of a Randomized Controlled Trial

Feasibility, Repeatability, and Correlation to Lung Function of Phase‐Resolved Functional Lung (PREFUL) MRI‐derived Pulmonary Artery Pulse Wave Velocity Measurements

Phase-Resolved Functional Lung MRI for Pulmonary Ventilation and Perfusion (V/Q) Assessment

Influence of echo time on pulmonary ventilation and perfusion derived by phase‐resolved functional lung (PREFUL) MRI using multi‐echo ultrashort echo time acquisition

Phase-Resolved Functional Lung (PREFUL) MRI to Quantify Ventilation: Feasibility and Physiological Relevance in Severe Asthma

Three-Dimensional Phase Resolved Functional Lung Magnetic Resonance Imaging

Phase‐Resolved Functional Lung (PREFUL) MRI May Reveal Distinct Pulmonary Perfusion Defects in Postacute COVID‐19 Syndrome: Sex, Hospitalization, and Dyspnea Heterogeneity

Comparison of 3D UTE free-breathing lung MRI with hyperpolarized 129Xe MRI in pediatric cystic fibrosis

Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseases

Influence of gadolinium, field-strength and sequence type on quantified perfusion values in phase-resolved functional lung MRI

A synthetic lung model (ASYLUM) for validation of functional lung imaging methods shows significant differences between signal-based and deformation-field-based ventilation measurements

Phase-Resolved Functional Lung (PREFUL)-MRI-derived parameters in evaluating chronic thromboembolic pulmonary disease: a prospective study